SEM

SELECT MEDICAL CORPORATION

SEM

Overview Fund Activity

Delisted

SEM was delisted on the 24th of February, 2005.

Back to rankings

Financial journalist opinion

SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

MECHANICSBURG, Pa. , Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced the appointment of Thomas P.

SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

Zacks Investment Research

Here's Why Select Medical (SEM) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Select Medical (SEM) is a Strong Momentum Stock

The Motley Fool

Select Medical (SEM) Q2 2025 Earnings Transcript

Image source: The Motley Fool.

Select Medical (SEM) Q2 2025 Earnings Transcript

Zacks Investment Research

Select Medical Shares Down 20% Despite Q2 Earnings Beat

SEM beats Q2 EPS estimates on strong Rehab admissions and higher revenue per patient day. Yet, shares drop 20.4% post-earnings.

Select Medical Shares Down 20% Despite Q2 Earnings Beat

Zacks Investment Research

Should Value Investors Buy Select Medical (SEM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Select Medical (SEM) Stock?

Zacks Investment Research

Here's Why Select Medical (SEM) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Select Medical (SEM) is a Strong Value Stock

Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript

Select Medical Holdings Corporation (NYSE:SEM ) Q2 2025 Earnings Conference Call August 1, 2025 9:00 AM ET Company Participants Michael F. Malatesta - Executive VP & CFO Robert A.

Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript

Zacks Investment Research

Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates

Select Medical (SEM) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.6 per share a year ago.

Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

MECHANICSBURG, Pa. , July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering

Select Medical Holdings remains a soft 'buy' due to attractive valuation, organic growth, and solid top-line performance despite recent share price decline. Legislative changes pose risks, particularly from reduced Medicaid coverage, but only a small portion of revenue is exposed to this headwind. Recent results show revenue growth and improving profitability from continuing operations, though some metrics like EBITDA and adjusted cash flow have softened.

Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering

See News Rankings

Charts implemented using Lightweight Charts™